Clearbridge BioLoc

AssayQuest™

Clearbridge BioLoc’s patent pending AssayQuest™ is an innovative and affordable analysis platform that can facilitate quantitative point-of-care-testing (POCT) from a small amount of patient sample.

The platform allows Test-Card to be customized with different reagent combinations and assay formats to provide quantitative and reproducible laboratory-quality results within minutes, aiding clinicians and other professionals in making rapid and well-informed decisions where time is critical.

Learn more …

AQroid™

AQroid is an Android-based image processing mobile application that generates quantifiable Point-of-Care Testing (POCT) data from existing third party test kits. It facilitates on-site data acquisition of instantaneous and quantitative results from a large variety of POCT kits: eliminating the inconsistencies of manual readings.

Learn more …

Latest Update


1 February 2012

CLEARBRIDGE BIOLOC AWARDED SPRING TECS PROOF-OF-VALUE (POV) GRANT

Clearbridge BioLoc was awarded with SPRING Singapore 's Technology Enterprise Commercialisation Scheme (TECS) Proof-of-Value (POV) Grant today. 

The TECS is a competitive grant awarded to start-ups posessing strong technology Intellectual Property in addition to a scalable business model. 

More information can be found here.  

About Us


About Clearbridge BioLoc

Clearbridge BioLoc is a Singapore-based company founded on innovative technology from a Korean partner with the aim of developing affordable and reliable Point-of-Care Testing (POCT) solutions.

Leveraging on novel yet cost-effective technological solutions, Clearbridge BioLoc’s fully automated analytical system, the AssayQuest®, enables remote and rapid processing of biological samples in small quantities, which would otherwise require complex laboratory testing. 

RECENT AWARDS: "Most Disruptive Technology Award", TechVenture 2011